PRA Health Sciences
Search results
1 day ago · ICON is the world's leading clinical research organisation, providing outsourced clincal development and commercialisation services to the pharmaceutical, biotechnology and medical device industries.
ICON plc is an Irish headquartered Nasdaq listed multinational healthcare intelligence and clinical research organisation that provides consulting, clinical development and commercialisation services for the pharmaceutical industry.
Healthcare Intelligence. Clinical Research. Evolved. Play. Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save lives and improve quality of life.
ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotech
Jun 4, 2024 · Investor Information. ICON is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations.
We work your way. As the world’s leading clinical research organisation powered by Healthcare Intelligence, and the largest global provider of functional service provision (FSP), ICON can transform organisational flexibility and operational efficiency.
Feb 22, 2022 · ICON plc is a world-leading healthcare intelligence and clinical research organisation. From molecule to medicine, we advance clinical research providing outsourced services to pharmaceutical, biotechnology, medical device and government and public health organisations.
Dublin, Ireland, February 22, 2022 – ICON plc (NASDAQ: ICLR), a world-leading healthcare intelligence and clinical research organisation, today reported its financial results for the fourth quarter and full year ended December 31, 2021.
ICON Hosts Investor Day and Updates Full Year 2024 Financial Guidance. 20 May, 2024. ICON plc to hold Investor Day Meeting on May 30, 2024. 09 May, 2024. ICON releases its ICON Cares 2023 Report. 30 April, 2024. ICON Announces Pricing of USD 2 Billion Notes. 24 April, 2024. ICON Reports First Quarter 2024 Results.
ICON plc | 525,550 followers on LinkedIn. Since our foundation in Dublin, Ireland in 1990, our mission has been to help our clients to accelerate the development of drugs and devices that save...
